BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19041054)

  • 21. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
    Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
    Xue HM; Xu HG; Huang K; Guo HX; Li Y; Zhou DH; Huang SL; Fang JP; Chen C
    Genet Mol Res; 2015 May; 14(2):5234-45. PubMed ID: 26125718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
    Weisdorf D; Spellman S; Haagenson M; Horowitz M; Lee S; Anasetti C; Setterholm M; Drexler R; Maiers M; King R; Confer D; Klein J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):748-58. PubMed ID: 18541193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry.
    Chowdhury AS; Maiers M; Spellman SR; Deshpande T; Bolon YT; Devine SM
    Transplant Cell Ther; 2023 Nov; 29(11):686.e1-686.e8. PubMed ID: 37586457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of partially mismatched related donors extends access to allogeneic marrow transplant.
    Henslee-Downey PJ; Abhyankar SH; Parrish RS; Pati AR; Godder KT; Neglia WJ; Goon-Johnson KS; Geier SS; Lee CG; Gee AP
    Blood; 1997 May; 89(10):3864-72. PubMed ID: 9160695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor.
    Fingerson S; Maiers M; Bolon YT; Devine SM; Spellman SR
    Blood Adv; 2024 Feb; 8(3):758-765. PubMed ID: 38127270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.
    Gragert L; Eapen M; Williams E; Freeman J; Spellman S; Baitty R; Hartzman R; Rizzo JD; Horowitz M; Confer D; Maiers M
    N Engl J Med; 2014 Jul; 371(4):339-48. PubMed ID: 25054717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia.
    Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Morishima Y; Kodera Y;
    Blood; 2011 Sep; 118(11):3186-90. PubMed ID: 21757619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
    Drobyski WR; Klein J; Flomenberg N; Pietryga D; Vesole DH; Margolis DA; Keever-Taylor CA
    Blood; 2002 Feb; 99(3):806-14. PubMed ID: 11806980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
    Kumar R; Kimura F; Ahn KW; Hu ZH; Kuwatsuka Y; Klein JP; Pasquini M; Miyamura K; Kato K; Yoshimi A; Inamoto Y; Ichinohe T; Wood WA; Wirk B; Seftel M; Rowlings P; Marks DI; Schultz KR; Gupta V; Dedeken L; George B; Cahn JY; Szer J; Lee JW; Ho AY; Fasth A; Hahn T; Khera N; Dalal J; Bonfim C; Aljurf M; Atsuta Y; Saber W
    Biol Blood Marrow Transplant; 2016 May; 22(5):932-40. PubMed ID: 26797402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matched unrelated donor transplants-State of the art in the 21st century.
    Altaf SY; Apperley JF; Olavarria E
    Semin Hematol; 2016 Oct; 53(4):221-229. PubMed ID: 27788759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.
    Barker JN; Boughan K; Dahi PB; Devlin SM; Maloy MA; Naputo K; Mazis CM; Davis E; Nhaissi M; Wells D; Cooper C; Ponce DM; Kernan N; Scaradavou A; Giralt SA; Papadopoulos EB; Politikos I
    Blood Adv; 2019 Apr; 3(7):939-944. PubMed ID: 30917950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.
    Wagner JE; Rosenthal J; Sweetman R; Shu XO; Davies SM; Ramsay NK; McGlave PB; Sender L; Cairo MS
    Blood; 1996 Aug; 88(3):795-802. PubMed ID: 8704232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
    Anasetti C; Hansen JA
    Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Perkins HA; Kollman C; Howe CW
    Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race as a factor in donor selection and survival of children with hematologic malignancies undergoing hematopoietic stem cell transplant in Florida.
    Horn B; Lamba N; Chellapandian D; Sunkersett G; Silva JG; Ziga E; Alperstein W; Joyce M; Castillo P; Fort J; Zhao J; Oshrine B
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29180. PubMed ID: 34121322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.